Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

104.06
Delayed Data
As of Mar 27
 +4.42 / +4.44%
Today’s Change
47.03
Today|||52-Week Range
121.93
+7.28%
Year-to-Date

Today’s Trading

Previous close99.64
Today’s open99.75
Day’s range99.72 - 104.96
Volume850,161
Average volume (3 months)742,771
Market cap$8.7B
Dividend yield--
Data as of 4:00pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)-234.48%
Earnings growth (this year)+38.62%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+7.20%
P/E ratioNM
Price/Sales142.50
Price/Book8.58

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...+0.97+1.46%
ISISIsis Pharmaceuticals...+2.22+3.63%
ICLRICON PLC+0.85+1.22%
CRLCharles River Labora...+0.60+0.76%
Data as of 4:02pm ET, 03/27/2015

Financials

Next reporting dateMay 4, 2015
EPS forecast (this quarter)-$0.66
Annual revenue (last year)$50.6M
Annual profit (last year)-$360.4M
Net profit margin-712.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account